The promise of stem cells lies in their unique ability to differentiate into a multitude of different types of cells. But in order to determine how to use stem cells for new therapeutics, scientists ...

A graft can be a life-saving device for coronary heart disease, which remains the leading cause of death for both men and women in the United States. However, at small diameters — such as the coronary ...

Researchers from St. Petersburg provided a unique experiment. They implanted a polymer scaffold as a vascular prosthesis into the rat abdominal aorta and monitored the process of its bioresobtion for ...

DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc., a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, ...

A study of seriously ill patients on kidney dialysis who were the first to receive tissue grafts engineered from their own adult cells has delivered promising results. The long-awaited findings are ...

Just as a climbing plant needs the right trellis to thrive, a small-diameter tissue-engineered vascular graft (TEVG) needs the right scaffold to transform seeded cells into a native-like artery that ...

Tissue engineering is a burgeoning academic field, however, the clinical and therapeutic promise of tissue and organ replacement has remained largely unrealized. With the possible exceptions of skin, ...

Regenerative tissue developer Humacyte Inc. has posted positive top-line phase II/III results for its Human Acellular Vessel, a tissue-engineered graft consisting entirely of decellularized ...

DURHAM, N.C., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (HUMA), a biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today ...

To date, no synthetic-based approach has been able to match the efficacy of native veins for vascular reconstruction. While approaches to creating TEBVs have clearly evolved over the past 20 years, ...

– Positive responses from surgeons and trauma centers to initial sales and marketing outreach – To communicate the health economic value of Symvess, Humacyte has developed a Budget Impact Model (BIM) ...